Key facts
- Lumps and nodules
- Early: a bolus, superficial placement or swelling. Late: an inflammatory nodule, biofilm or granuloma months or years on
- Migration
- Product moving along a tissue plane under muscle action or excess volume; lips, tear troughs and nasolabial folds most often
- Tyndall tint
- A bluish or grey cast where hyaluronic acid sits too close to the surface under thin skin
- Overfilling
- Accumulated product from repeated treatments without checking what is already there; a heavier face with the same sag
- Vascular occlusion
- Product blocking or pressing on an artery; blanching, dusky or mottled skin and disproportionate pain need same-day care
- Reversible
- Hyaluronic acid, with hyaluronidase after examination; CaHA, PCL and PLLA are managed, not dissolved
Why do lumps and nodules form after filler, early and late?
Early lumps form when a bolus of product sits where it can be felt, when filler is placed too superficially for the area, or when swelling and bruising around the injection points make the tissue uneven for a time. Dermal fillers are gels placed in a chosen tissue plane, and a lump in the first weeks is usually product or swelling rather than a reaction; it is assessed once the swelling has settled, not treated on the day it appears.
Late nodules are different. A firm lump that appears months or years after injection can be a delayed-onset inflammatory nodule, a biofilm, in which bacteria colonise the filler surface, or a granuloma, a foreign-body reaction. Triggers described in the literature include infection or immune stimulus elsewhere in the body. These are examined rather than massaged, and management ranges from antibiotics and injected medication to dissolving, where the product is hyaluronic acid. The complication care page sets out which lumps need prompt review.
Why does filler migrate, and where does it go?
Filler migrates when product placed in a mobile plane is pushed along it by muscle action, when more volume has been placed than the compartment can hold, or when repeated treatments have layered product until it spills beyond the intended zone. Lips are the commonest site, where product drifts above the vermilion border into the upper lip and philtrum; tear-trough filler can slide down onto the cheek and show as puffiness; nasolabial filler can shift with every smile.
Migrated hyaluronic acid can be mapped with ultrasound and dissolved in a targeted way. Migrated CaHA or PCL cannot be dissolved and is managed as the material resorbs. The volume restoration page explains why structure is assessed before volume is added, which is the planning step that keeps product where it belongs.
“A filler adds volume. It does not lift, and it does not tighten. Asking it to do either is how faces end up over-filled.”
Dr Sin YongOn the dermal fillers Singapore page
What is the Tyndall effect, and can it be removed?
The Tyndall effect is a bluish or grey tint seen where hyaluronic acid filler sits too close to the surface under thin skin, most often in the tear trough and sometimes in the lips or fine lines. The gel scatters light differently from the tissue around it, and under thin skin that difference reads as colour. It does not fade on its own while the product remains.
Because it is hyaluronic acid, it can be dissolved with hyaluronidase after examination, and the area reassessed before any product is replaced in a deeper plane or with a different material. The filler correction page describes the Tyndall tint among the problems it addresses, and why the tear trough so often ends up needing correction.
Filler problems by material: what can be dissolved and what is managed| Problem | Usual mechanism | Hyaluronic acid | CaHA, PCL or PLLA |
|---|
| Early lump | Bolus, superficial placement or swelling | Reviewed once settled; dissolved if product | Reviewed; massaged early only if advised; not dissolved |
| Late nodule | Inflammatory reaction, biofilm or granuloma | Antibiotics or injected medication; dissolving | Antibiotics or injected medication; waits for resorption |
| Migration | Muscle action, excess volume, repeated layering | Mapped with ultrasound and dissolved in stages | Managed as the material resorbs |
| Tyndall tint | Gel too close to the surface under thin skin | Dissolved, then reassessed | Not typical; these materials are not placed superficially |
| Overfilled face | Accumulated product over repeated treatments | Planned, staged dissolving with review | Time, no further product, reassessment |
| Vascular occlusion | Product blocking or pressing on an artery | Urgent high-dose hyaluronidase | Supportive care; same-day assessment regardless |
How does an overfilled face happen, and can it be undone?
An overfilled face happens by accumulation. Hyaluronic acid can remain in tissue after its visible effect has faded, so repeated treatments added without checking what is already there build up, and the face becomes heavier, rounder and less mobile while the underlying sag is unchanged. Asking filler to do the work of a lift is the usual starting point, because a face whose main change is descent gains volume it did not need and keeps the sag it had.
It can usually be undone in stages. Existing product is mapped, with ultrasound where the history is unclear, and hyaluronic acid is dissolved in a planned, targeted way rather than all at once, followed by review before anything is replaced. Where the product is CaHA, PCL or PLLA, the face is managed as the material resorbs. Dr Sin Yong's position is that nobody wakes up overfilled; it arrives one reasonable appointment at a time, which is why what is already present is checked before anything is added.
What is vascular occlusion, and why is it the emergency?
Vascular occlusion is filler entering or pressing on an artery so that the skin it supplies loses its blood flow. The warning signs are skin that blanches white or turns dusky, purple or net-like, and pain out of proportion to the injection; these need assessment the same day, and any change in vision after filler means the nearest hospital emergency department or 995, not a clinic. The highest-risk zones are the nose, the glabella, the forehead and the tear trough, where arteries connect with the circulation of the eye.
For hyaluronic acid the treatment is urgent, high-dose hyaluronidase, which is kept in the room wherever hyaluronic acid is injected. For the materials that cannot be dissolved, management is supportive and case by case, which is one reason they are placed conservatively. The vascular occlusion warning signs page sets out what to do in the first hour and how an occlusion differs from a bruise.
What can hyaluronidase reverse, and what cannot be dissolved?
Hyaluronidase dissolves hyaluronic acid and nothing else. Lumps, migration, the Tyndall tint and overfilling from hyaluronic acid can therefore be addressed by dissolving, after examination and often in stages. Calcium hydroxylapatite (Radiesse), polycaprolactone (Ellansé) and poly-L-lactic acid (Sculptra) do not respond to it; problems after those products are managed with time, injected medication where an inflammatory nodule is confirmed, and occasionally referral, as the material resorbs on its own timeline.
That single fact is why hyaluronic acid is the usual first choice for someone new to filler and the only choice in the tear trough, and why a problem after an unknown product starts with finding out what it is. Hyaluronidase is itself a medical treatment with its own considerations, including allergy, which is screened for, and whether and how much to use is decided after examination, not over a message.
